Case Studies

From StemRNA™ Clinical Seed Clone to GMP-Ready Cell Therapy Programs

Discover how REPROCELL’s StemRNA™ Clinical iPSC Seed Clones streamline the path to GMP-ready cell therapy, simplifying regulatory processes and enabling scalable, high-quality manufacturing.

27 February 2026

Preserving the Microenvironment-Advances in Ex Vivo Colonic Tissue Culture for IBD Drug Discovery

Advances in ex vivo colonic tissue culture preserve the microenvironment, enhancing IBD drug discovery by maintaining native tissue architecture and immune complexity for more predictive research models.

26 February 2026

Integrating AI with Ex Vivo Data: How Machine Learning Is Enhancing Predictive Accuracy in Human Tissue Studies

Discover how integrating AI with ex vivo human tissue data is revolutionizing drug discovery by enhancing predictive accuracy and bridging the gap between preclinical and clinical research.

12 February 2026

The Critical Role of Central Laboratory Services in Regulatory Compliance and Data Integrity

Explore the critical role of Central Laboratory Services in ensuring data integrity and regulatory compliance in drug development. Learn how CLS supports reliable, reproducible, and auditable data.

27 January 2026